Literature DB >> 23223873

[ASAS/EULAR recommendations for the management of ankylosing spondylitis : evaluation of the 2010 update in the German-speaking area].

U Kiltz1, J Sieper, J Braun.   

Abstract

The ASAS/EULAR recommendations for the management of ankylosing spondylitis have been updated in 2010. The recommendations have been extended from 10 to 11 recommendations and 4 superior principles have been introduced based on the level of evidence and expert knowledge. The recommendations have been translated into German and have been evaluated by 25 experts from Germany, Austria and Switzerland. The experts scored the strength of the recommendations (SOR) on an 11 point numerical rating scale (from 0 = no agreement to 10 = total agreement). With a mean score of 9.6 ± 1.05 the SOR was generally very good.

Entities:  

Mesh：

Year:  2013        PMID： 23223873     DOI： 10.1007/s00393-012-1071-z

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN： 0340-1855            Impact factor:   1.372


  33 in total

1.  [Dissemination and evaluation of ASAS/EULAR recommendations for the management of ankylosing spondylitis in Europe].

Authors:  J Braun; J Sieper
Journal:  Z Rheumatol       Date:  2009-07       Impact factor: 1.372

2.  Combination treatment with etanercept and an intensive spa rehabilitation program in active ankylosing spondylitis.

Authors:  M Colina; G Ciancio; R Garavini; M Conti; F Trotta; M Govoni
Journal:  Int J Immunopathol Pharmacol       Date:  2009 Oct-Dec       Impact factor: 3.219

3.  EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.

Authors:  M J L Peters; D P M Symmons; D McCarey; B A C Dijkmans; P Nicola; T K Kvien; I B McInnes; H Haentzschel; M A Gonzalez-Gay; S Provan; A Semb; P Sidiropoulos; G Kitas; Y M Smulders; M Soubrier; Z Szekanecz; N Sattar; M T Nurmohamed
Journal:  Ann Rheum Dis       Date:  2009-09-22       Impact factor: 19.103

Review 4.  Methotrexate for ankylosing spondylitis.

Authors:  J Chen; C Liu; J Lin
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

5.  The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal.

Authors:  M Rudwaleit; R Landewé; D van der Heijde; J Listing; J Brandt; J Braun; R Burgos-Vargas; E Collantes-Estevez; J Davis; B Dijkmans; M Dougados; P Emery; I E van der Horst-Bruinsma; R Inman; M A Khan; M Leirisalo-Repo; S van der Linden; W P Maksymowych; H Mielants; I Olivieri; R Sturrock; K de Vlam; J Sieper
Journal:  Ann Rheum Dis       Date:  2009-03-17       Impact factor: 19.103

6.  The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.

Authors:  M Rudwaleit; D van der Heijde; R Landewé; J Listing; N Akkoc; J Brandt; J Braun; C T Chou; E Collantes-Estevez; M Dougados; F Huang; J Gu; M A Khan; Y Kirazli; W P Maksymowych; H Mielants; I J Sørensen; S Ozgocmen; E Roussou; R Valle-Oñate; U Weber; J Wei; J Sieper
Journal:  Ann Rheum Dis       Date:  2009-03-17       Impact factor: 19.103

7.  [German patient version of the ASAS/EULAR recommendations for the management of ankylosing spondylitis].

Authors:  U Kiltz; E Feldtkeller; J Braun
Journal:  Z Rheumatol       Date:  2010-03       Impact factor: 1.372

8.  ASAS/WHO ICF Core Sets for ankylosing spondylitis (AS): how to classify the impact of AS on functioning and health.

Authors:  A Boonen; J Braun; I E van der Horst Bruinsma; F Huang; W Maksymowych; N Kostanjsek; A Cieza; G Stucki; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2010-01       Impact factor: 19.103

Review 9.  Physiotherapy interventions for ankylosing spondylitis.

Authors:  H Dagfinrud; T K Kvien; K B Hagen
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

10.  2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis.

Authors:  J Braun; R van den Berg; X Baraliakos; H Boehm; R Burgos-Vargas; E Collantes-Estevez; H Dagfinrud; B Dijkmans; M Dougados; P Emery; P Geher; M Hammoudeh; R D Inman; M Jongkees; M A Khan; U Kiltz; Tk Kvien; M Leirisalo-Repo; W P Maksymowych; I Olivieri; K Pavelka; J Sieper; E Stanislawska-Biernat; D Wendling; S Ozgocmen; C van Drogen; Bj van Royen; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2011-06       Impact factor: 19.103
View more
  5 in total

Review 1.  [What is ascertained in the therapy of axial spondyloarthritis?].

Authors:  J Braun; X Baraliakos; F Heldmann; U Kiltz
Journal:  Internist (Berl)       Date:  2013-12       Impact factor: 0.743

2.  Dose reduction of recombinant human tumor necrosis factor inhibitors (etanercept) can be effective in ankylosing spondylitis patients with synovitis of the hip in a Chinese population.

Authors:  Jitian Li; Xiaoqing Wang; Zongchang Han; Yonghong Zhang; Yuli Wang; Yishan Zhang; Wuyin Li
Journal:  Int J Immunopathol Pharmacol       Date:  2016-07-05       Impact factor: 3.219

3.  The comparative efficacy of group- versus home-based exercise programs in patients with ankylosing spondylitis: Protocol for a meta-analysis.

Authors:  Hui Liang; Xu Tian; Xiao-Ling Liu; Shu-Ya Wang; Yi Dai; Li Kang; Li-Sai Chen; Li-Fen Jin
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

4.  Relationship of CARD8 Gene Polymorphisms with Susceptibility to Ankylosing Spondylitis: A Case-Control Study.

Authors:  Haitao Xu; Bo Li
Journal:  Med Sci Monit       Date:  2020-02-21

5.  The comparative efficacy of supervised- versus home-based exercise programs in patients with ankylosing spondylitis: A meta-analysis.

Authors:  Hui Liang; Lingli Xu; Xu Tian; Shuya Wang; Xiaoling Liu; Yi Dai; Li Kang; Lisai Chen; Lifen Jin; Qin Li; Weiqing Chen
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.